A comparative study of tirofiban plus enoxaparin versus enoxaparin alone along with dual antiplatelet blockade in the management of patients with non-ST elevation acute coronary syndrome

A comparative study of tirofiban plus enoxaparin versus enoxaparin alone along with dual antiplatelet blockade in the management of patients with non-ST elevation acute coronary syndrome

Introduction: Antithrombotic therapy in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) includes dual antiplatelet therapy (DAPT) along with enoxaparin. However, resistance to antiplatelet action of aspirin and clopidogrel is well known and is about 27% (0-57%) and 30%, respectivel...

Full description

Bibliographic Details
Main Authors: Monika Bhandari, Pravesh Vishwakarma, Mukul Misra, Varun Shankar Narain, Akshyaya Pradhan, Rishi Sethi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Heart India
Subjects:
Antiplatelet resistance
GPIIb/IIIa inhibitors
myocardial infarction
non-ST elevation NSTE-ACS
Online Access:http://www.heartindia.net/article.asp?issn=2321-449x;year=2018;volume=6;issue=3;spage=97;epage=101;aulast=Bhandari

Internet

http://www.heartindia.net/article.asp?issn=2321-449x;year=2018;volume=6;issue=3;spage=97;epage=101;aulast=Bhandari

Similar Items